# Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomian Gland Dysfunction

> **NCT00705510** · PHASE4 · COMPLETED · sponsor: **Mahidol University** · enrollment: 70 (actual)

## Conditions studied

- Meibomian Gland Dysfunction

## Interventions

- **DRUG:** 0.05% cyclosporin eye drop

## Key facts

- **NCT ID:** NCT00705510
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2010-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00705510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00705510, "Efficacy of 0.05 % Cyclosporine Ophthalmic Emulsion Compare With Tear in Meibomian Gland Dysfunction". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00705510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*